Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;23(1):444-458.
doi: 10.4314/ahs.v23i1.47.

Clinicopathological, immunohistochemical, molecular-genetic and risk profiles of gastrointestinal stromal tumors in a cohort of Sudanese patients

Affiliations

Clinicopathological, immunohistochemical, molecular-genetic and risk profiles of gastrointestinal stromal tumors in a cohort of Sudanese patients

Nazik Elmalaika Husain et al. Afr Health Sci. 2023 Mar.

Abstract

Background: Determining the risk of malignant behaviour and mutational status of gastrointestinal stromal tumours (GISTs) guide the management decision and allow optimal individualized patient treatment.

Objectives: To determine clinicopathological, immunohistochemical (IHC), risk and KIT mutational findings of GISTs in Sudanese patients.

Methods: Histological slides were reviewed, IHC for DOG-1 and CD117 performed and hotspot KIT mutations examined. The risk group was assigned using combined risk criteria.

Results: 21 of the 36 patients (58.3%) were males (mean age, 54.83 ±12.57; range, 26-71). Abdominal pain and mass were the most frequent symptoms. Mean tumor size (±SD) was 11.6(±5.82) cm. Either CD117, DOG1 or both were positive in all cases. Using risk criteria, 33.3% (n=12) were clinically malignant at presentation, 13.9% (n=5) high risk, 16.7% (n=6) intermediate, 27.8% (n=10) low risk and 2.8% (n=1) very low risk. Sixteen of 23 (70%) tested cases had KIT (14 exon 11 and two exon 9) mutations. Six tumors were wild type. Exon 11 deletions (p.I563-L576 del and p.V559-N566delinsD) significantly correlate with disease recurrence (p-value: 0.028).

Conclusions: Sudanese patients with GIST tend to present late. Nearly half of them correspond to the malignant/high-risk category. The frequency of KIT mutations (79.31%) is in line with the literature.

Keywords: DOG1; GIST; Gastrointestinal stromal tumour; Imatinib; KIT; genotyping; malignant behaviour; metastasis; risk assessment; risk stratification; tumour rupture.

PubMed Disclaimer

Conflict of interest statement

Authors declare that they have any competing interests.

Figures

Figure 1
Figure 1
A: Intestinal GIST with spindle cell histologic pattern (H&E, X400). B: Gastric epithelioid GIST exhibiting signet ring-like vacuolated cytoplasm (H&E, X400). C: Epithelioid GIST showing monotonous epithelioid morphology with fine reticular fibrosis resulting in organoid nesting pattern (H&E, X400). D: CD117 Immunohistochemical (IHC) expression in spindle cell GIST (CD117 IHC, X400). E: Epithelioid GIST showing strong membranous positivity for DOG1 (DOG1 IHC, X400). F: Gastric epithelioid GIST showing cytoplasmic and characteristic strong Golgi-pattern (arrow) positivity for PDGFRA (PDGFRA IHC, X400).

Similar articles

Cited by

References

    1. Gupta SK, Rateria N. Gastrointestinal Stromal Tumors (GIST): an Overview. Indian Journal of Surgery. 2020:1–7. - PubMed
    1. Khoo CY, et al. Systematic review of current prognostication systems for primary gastrointestinal stromal tumors. European Journal of Surgical Oncology. 2018 - PubMed
    1. Miettinen M, Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol. 2003;54(1):3–24. - PubMed
    1. Fletcher CD, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Human pathology. 2002;33(5):459–465. - PubMed
    1. Agaimy A. Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting. International Journal of Clinical and Experimental Pathology. 2010;3(5):461–471. - PMC - PubMed

LinkOut - more resources